Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Falcon

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 933Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Solid Biosciences Gets FDA Rare Pediatric Disease Designation
    Solid Biosciences Gets FDA Rare Pediatric Disease Designation

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196939/0/en/Solid-Biosciences-Receives-FDA-Rare-Pediatric-Disease-Designation-for-SGT-212-Dual-Route-of-Administration-Gene-Therapy-for-Friedreich-s-Ataxia.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Skyhawk Therapeutics Reports Positive Phase 1 Results
    Skyhawk Therapeutics Reports Positive Phase 1 Results

    17 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/skyhawk-therapeutics-announces-positive-first-interim-results-in-patients-from-its-phase-1-clinical-trial-of-sky-0515-as-a-treatment-for-huntingtons-disease-302559083.html

    PR NEWSWIRE
    17 Sep 2025
    Share Share
    Alcyone secures funding for pediatric precision Therapeutics
    Alcyone secures funding for pediatric precision Therapeutics

    24 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alcyone-therapeutics-announces-strategic-financing-to-advance-an-expanded-pipeline-of-pediatric-focused-precision-therapeutics-for-severe-neurological-diseases-302436946.html

    PR NEWSWIRE
    24 Apr 2025
    Share Share
    Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
    Galapagos reports initiation of FALCON clinical trial in cystic fibrosis

    24 Apr 2018

    // FINANCE

    https://finance.yahoo.com/news/galapagos-reports-initiation-falcon-clinical-064626530.html

    FINANCE
    24 Apr 2018
    Share Share